The TMPRSS2-ERG fusion oncogene is thought to be important during tumor progression and development as it is found in approximately half of all prostate cancer (PCa) biopsies and also in metastases (1–3). This evidence concerns the gene TMPRSS2 and posterior cortical atrophy.